Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma

par Almeida, Filipe V, Douglass, Stephen M., Fane, Mitchell E., Weeraratna, Ashani T.
Publié dans Pigment Cell Melanoma Res (2018)

Genetic screening for single-cell variability modulators driving therapy resistance

par Torre, Eduardo A., Arai, Eri, Bayatpour, Sareh, Jiang, Connie L., Beck, Lauren E., Emert, Benjamin L., Shaffer, Sydney M., Mellis, Ian A., Fane, Mitchell E., Alicea, Gretchen M., Budinich, Krista A., Weeraratna, Ashani T., Shi, Junwei, Raj, Arjun
Publié dans Nat Genet (2021)

NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF

par Fane, Mitchell E., Chhabra, Yash, Hollingsworth, David E.J., Simmons, Jacinta L., Spoerri, Loredana, Oh, Tae Gyu, Chauhan, Jagat, Chin, Toby, Harris, Lachlan, Harvey, Tracey J., Muscat, George E.O., Goding, Colin R., Sturm, Richard A, Haass, Nikolas K., Boyle, Glen M., Piper, Michael, Smith, Aaron G.
Publié dans EBioMedicine (2017)

Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2

par Alicea, Gretchen M., Rebecca, Vito W., Goldman, Aaron R., Fane, Mitchell E., Douglass, Stephen M., Behera, Reeti, Webster, Marie R., Kugel, Curtis H., Ecker, Brett L., Caino, M. Cecilia, Kossenkov, Andrew V., Tang, Hsin-Yao, Frederick, Dennie T., Flaherty, Keith T., Xu, Xiaowei, Liu, Qin, Gabrilovich, Dmitry I., Herlyn, Meenhard, Blair, Ian A., Schug, Zachary T., Speicher, David W., Weeraratna, Ashani T.
Publié dans Cancer Discov (2020)

Paradoxical role for wild type p53 in driving therapy resistance in melanoma

par Webster, Marie R, Fane, Mitchell E, Alicea, Gretchen M, Basu, Subhasree, Kossenkov, Andrew V, Marino, Gloria E, Douglass, Stephen M, Kaur, Amanpreet, Ecker, Brett L, Gnanapradeepan, Keerthana, Ndoye, Abibatou, Kugel, Curtis, Valiga, Alexander, Palmer, Jessica, Liu, Qin, Xu, Xiaowei, Morris, Jessicamarie, Yin, Xiangfan, Wu, Hong, Xu, Wei, Zheng, Cathy, Karakousis, Giorgos C, Amaravadi, Ravi K, Mitchell, Tara C, Almeida, Filipe V, Xiao, Min, Rebecca, Vito W, Wang, Ying-Jie, Schuchter, Lynn M, Herlyn, Meenhard, Murphy, Maureen E, Weeraratna, Ashani T
Publié dans Mol Cell (2019)

Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma

par Webster, Marie R., Fane, Mitchell E., Alicea, Gretchen M., Basu, Subhasree, Kossenkov, Andrew V., Marino, Gloria E., Douglass, Stephen M., Kaur, Amanpreet, Ecker, Brett L., Gnanapradeepan, Keerthana, Ndoye, Abibatou, Kugel, Curtis, Valiga, Alexander, Palmer, Jessica, Liu, Qin, Xu, Xiaowei, Morris, Jessicamarie, Yin, Xiangfan, Wu, Hong, Xu, Wei, Zheng, Cathy, Karakousis, Giorgos C., Amaravadi, Ravi K., Mitchell, Tara C., Almeida, Filipe V., Xiao, Min, Rebecca, Vito W., Wang, Ying-Jie, Schuchter, Lynn M., Herlyn, Meenhard, Murphy, Maureen E., Weeraratna, Ashani T.
Publié dans Mol Cell (2020)